| # | Drug | Count |
|---|---|---|
| 0 | DROSPIRENONE AND ETHINYL ESTRADIOL | 1490 |
| 1 | OMEPRAZOLE MAGNESIUM | 635 |
| 2 | ASPIRIN | 494 |
| 3 | ASPIRIN 325 MG | 485 |
| 4 | ASPIRIN 81 MG | 485 |
| 5 | IBUPROFEN | 482 |
| 6 | OMEPRAZOLE | 478 |
| 7 | ACETAMINOPHEN | 469 |
| 8 | METHOTREXATE SODIUM | 444 |
| 9 | FUROSEMIDE | 438 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DROSPIRENONE AND ETHINYL ESTRADIOL | 1490 | 0.0338 |
| 1 | SODIUM MONOFLUOROPHOSPHATE | 6 | 0.0162 |
| 2 | OLMESARTAN MEDOXOMIL-HYDROCHLOROTHIAZIDE | 91 | 0.0123 |
| 3 | ONTRUZANT | 6 | 0.0115 |
| 4 | BETAXOLOL | 9 | 0.0110 |
| 5 | OLMESARTAN MEDOXOMIL / AMLODIPINE BESYLATE / HYDROCHLOROTHIAZIDE | 13 | 0.0105 |
| 6 | MOSUNETUZUMAB | 10 | 0.0090 |
| 7 | FLUTAMIDE | 8 | 0.0081 |
| 8 | CLORAZEPATE DIPOTASSIUM | 14 | 0.0071 |
| 9 | PHENOBARBITAL, HYOSCYAMINE SULFATE, ATROPINE SULFATE, SCOPOLAMINE HYDROBROMIDE | 6 | 0.0065 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 1448 |
| 1 | Corticosteroid [EPC] | 1201 |
| 2 | Proton Pump Inhibitor [EPC] | 828 |
| 3 | GLP-1 Receptor Agonist [EPC] | 792 |
| 4 | Benzodiazepine [EPC] | 660 |
| 5 | Platelet Aggregation Inhibitor [EPC] | 520 |
| 6 | Loop Diuretic [EPC] | 501 |
| 7 | Vitamin C [EPC] | 432 |
| 8 | Folate Analog Metabolic Inhibitor [EPC] | 412 |
| 9 | HMG-CoA Reductase Inhibitor [EPC] | 375 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Complement C5 Inhibitor [EPC] | 4 | 0.0331 |
| 1 | Antithrombin-directed RNA Interaction [EPC] | 1 | 0.0179 |
| 2 | Cholecystokinin Analog [EPC] | 1 | 0.0065 |
| 3 | Complement Factor D Inhibitor [EPC] | 2 | 0.0065 |
| 4 | Small Interfering RNA [EPC] | 1 | 0.0063 |
| 5 | GLP-2 Analog [EPC] | 62 | 0.0046 |
| 6 | Asparagine-specific Enzyme [EPC] | 53 | 0.0039 |
| 7 | CD33-directed Immunoconjugate [EPC] | 13 | 0.0035 |
| 8 | Melanocortin 4 Receptor Agonist [EPC] | 1 | 0.0035 |
| 9 | Lipid-based Polyene Antifungal [EPC] | 45 | 0.0035 |